Tag: virusPHIX-P9

Innovation, Research

QCMD to use RNAssist’s virusPHIX-P9 Biomolecule Stabilization Technology in its SARS-CoV-2 antigen EQA scheme

March 10, 2021

Via: The Medical News

In a further development of the collaboration between QCMD and RNAssist, QCMD will use the universal biological sample stabilization virusPHIX-P9™ as the matrix within its forthcoming SARS-CoV-2 antigen EQA pilot scheme. Studies have proven that virusPHIX-P9™ is both capable of […]